IMOIMO
US • —
$112.02
P/E
19.09
PEG
—
FCF Yield
—
Rev Growth YoY
-9.1% YoY
Gross Margin
19.9%
Health Score
6/10
D/E Ratio
0.17
Confidence
LOW
Business Snapshot
Imperial Oil Limited operates as an integrated energy company involved in the exploration, production, and sale of crude oil and natural gas, as well as the refining and marketing of petroleum products. The company primarily operates in Canada, with a strong presence in the oil sands and conventional oil and gas segments. As a well-established player in the Canadian energy market, Imperial Oil benefits from its integrated business model, which provides some insulation from volatility in any single segment. A key defining characteristic is its conservative financial management, reflected in the company's low debt levels.
Financial Health
Gross margin stands at 19.9%, though the prior-year comparison is not available for trend assessment. Net margin is 6.2%, suggesting modest profitability after all expenses...
Risk Assessment
- REVENUE DECELERATION — Revenue declined 9.1% year-over-year, indicating a significant contraction in top-line performance.
- EARNINGS QUALITY — Net income dropped 37.1% year-over-year, far outpacing the revenue decline, pointing to compressed margins and operational challenges.
- TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed.
- VALUATION DIVERGENCE — No DCF data is available for comparison, preventing a fundamental check on the current market price relative to intrinsic value....
Gross margin stands at 19.9%, though the prior-year comparison is not available for trend assessment. Net margin is 6.2%, suggesting modest profitability after all expenses. The balance sheet is a clear strength, with a debt-to-equity ratio of only 0.17x, indicating a very conservative capital structure, and a current ratio of 1.33x, showing adequate short-term liquidity. Free cash flow data is unavailable, preventing a direct assessment of cash generation and yield. Overall financial health is supported by a strong balance sheet and positive margins, but the lack of free cash flow transparency introduces some uncertainty regarding dividend sustainability and reinvestment capacity.
- REVENUE DECELERATION — Revenue declined 9.1% year-over-year, indicating a significant contraction in top-line performance. - EARNINGS QUALITY — Net income dropped 37.1% year-over-year, far outpacing the revenue decline, pointing to compressed margins and operational challenges. - TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed. - VALUATION DIVERGENCE — No DCF data is available for comparison, preventing a fundamental check on the current market price relative to intrinsic value.
Unlock the full AI report
Full 8-section analysis includes:
Metric deep-dives